Daily Management Review

Mylan To Introduce ‘First Generic’ Injections For Allergy


08/31/2016


The first lot of EpiPen injections will be released with a discount.



On Monday, the 29th of August 2016, Mylan NV informed that it is ready to introduce the “first generic to its allergy auto-injector EpiPen”, which will be given at a discount rate, whereby reducing over fifty percent from the price list of the “branded product”.
 
Moreover, during the last week, for some patients the company brought down the “out-of-pocket costs of EpiPen”, while the “wave of critism” gushed in from the lawmakers and public alike for “rapid escalation in the product's price in the past few years”.
 
Mylan expects to launch its generic product at the price of “$300” in the list price, while the branded one costs around “$600”. Back in the year of 2008, EpiPen’s cost was around “$100”. While, Reuters reports:
“Mylan is the latest company to be caught up in the growing outrage at apparently egregious drug price increases. Valeant Pharmaceuticals International Inc (VRX.N) (VRX.TO) and privately held Turing Pharmaceuticals have both been publicly excoriated for similar price increases”.
 
Mylan acquired EpiPen in the year of 2007, which are “preloaded injections of epinephrine (adrenaline)”. The said drug is used to contain “dangerous allergic reaction” called “anaphylaxis” which can prove fatal.
 
Couple of minutes exposure to the “allergen” can cause anaphylaxis, while the same can be due some food items like “peanuts”, or due to some insects as common as bees. However, certain medications can also lead to “a severe reaction”. Mylan is based out of Netherlands, which intends on continuing its trading and distribution of “branded EpiPen”.
 
 
 
 
References:
http://www.reuters.com/







Science & Technology

A City Is Can Be Converted To A Living Organism, Showcases China’s Huawei

Workers Would Be Helped To Lift More By These Robotic Vests

British Parliament to assess impact of e-cigarettes

Wind energy will provide 30% of Europe's needs by 2030

A Major Platform For Artificial Intelligence Is Its Mobile Devices: Apple

Rumor: Apple will release a budget version of iPhoneX

With China Set To Dominate, 1 Billion Could Be Using 5G By 2023

Deutsche Telekom unveils next gen 5G mobile antennas in Europe

Diamonds are now the new gold

Expert Body Says Driving In A Driverless Car In An Inebriated Condition Or On Drugs Should Be Legalized

World Politics

World & Politics

Japan demands to lift embargo on food from Fukushima

Bernard Arnault clarifies on Le Monde’s “Paradise Paper” report

South Korea and the U.S. present a united front against the North Korean leadership

Europe is preparing an alternative to NATO

Ten smartest cities in the world

Parties of Germany seek a common ground to create a coalition

Special counsel Robert Mueller’s Russian probe could see its first arrest today

Losing Steam Is North Korea’s Relationship With China – The Former’s Sole Ally